-
公开(公告)号:US12168040B2
公开(公告)日:2024-12-17
申请号:US17168971
申请日:2021-02-05
Applicant: The Rockefeller University
Inventor: David Bikard , Luciano Marraffini
IPC: A61K38/46 , A01N63/00 , A61K31/7105 , A61K31/713 , A61K45/06 , C12N9/16 , C12N9/22 , C12N15/113 , C12N15/74
Abstract: Provided are compositions and methods for selectively reducing the amount of antibiotic resistant and/or virulent bacteria in a mixed bacteria population, or for reducing any other type of unwanted bacteria in a mixed bacteria population. The compositions and methods involve targeting bacteria that are differentiated from other members of the population by at least one unique clustered regularly interspaced short palindromic repeats (CRISPR) targeted DNA sequence. The compositions and methods can be readily adapted to target any bacteria or any bacteria plasmid, or both.
-
公开(公告)号:US12163130B2
公开(公告)日:2024-12-10
申请号:US17099209
申请日:2020-11-16
Inventor: Anne Schaefer , Paul Greengard , Chan Lek Tan
IPC: C12N15/113 , A01K67/0275 , A01K67/0276 , A61K38/18 , A61K49/00 , A61P25/00 , A61P25/08 , G01N33/50
Abstract: The invention is directed to compositions and methods for treating or reducing the likelihood of the development of epilepsy in an individual. The method comprises administering to the central nervous system of an individual in need of such treatment a therapeutically effective amount of an agent capable of increasing the expression and/or activity of miR-128.
-
公开(公告)号:US12141963B2
公开(公告)日:2024-11-12
申请号:US17282039
申请日:2019-10-04
Applicant: THE ROCKEFELLER UNIVERSITY
Inventor: Jakob Metzger , Fred Etoc , Ali Brivanlou , Eric Siggia
IPC: G06T7/62 , C12N5/0735 , G01N1/30 , G01N33/50 , G06F18/21 , G06F18/214 , G06N3/084 , G06T7/00 , G06V10/764 , G06V10/82 , G06V20/69 , G16B40/00
Abstract: Systems and methods for identifying molecules that are biologically active against a disease, where the method can comprise culturing a first mammalian cell population under organoid formation conditions in the presence of a test molecule to obtain a first organoid, wherein the first mammalian cell population, when cultured under the organoid formation conditions in the absence of the test molecule, results in an organoid with a disease phenotype; imaging the first organoid following exposure to the test molecule; analyzing one or more images of the first organoid using a neural network that has been trained to assign a probability score of disease or non-disease ranging between 0% and 100%; assigning the first organoid a probability score ranging between 0% and 100%; wherein the test molecule is biologically active against the disease if the probability score of the first organoid is greater than a cutoff probability score of non-disease or lower than a cutoff probability score of disease.
-
公开(公告)号:US12060619B2
公开(公告)日:2024-08-13
申请号:US17140409
申请日:2021-01-04
Applicant: The Rockefeller University
Inventor: Sohail Tavazoie , Nils Halberg , Kim Png
IPC: C12N15/113 , A61K38/17 , A61K39/395 , A61K45/06 , C07K16/18 , C12Q1/6886 , A61K39/00
CPC classification number: C12Q1/6886 , A61K38/1709 , A61K39/3955 , A61K45/06 , C07K16/18 , C12N15/113 , C12N15/1135 , A61K2039/505 , A61K2300/00 , C07K2317/73 , C07K2317/76 , C12N2310/113 , C12N2310/141 , C12N2320/11 , C12N2320/12 , C12N2330/31 , C12Q2600/106 , C12Q2600/118 , C12Q2600/136 , C12Q2600/158 , C12Q2600/16 , C12Q2600/178 , A61K38/1709 , A61K2300/00
Abstract: This invention concerns pathological angiogenesis and cancer, related treatment methods, and related compositions. Also disclosed are related diagnosis kits and methods.
-
公开(公告)号:US12054538B2
公开(公告)日:2024-08-06
申请号:US18046481
申请日:2022-10-13
Inventor: Ron Diskin , Pamela J. Bjorkman , Michel Nussenzweig , Johannes Scheid
IPC: C07K16/10
CPC classification number: C07K16/1063 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C12N2740/16111
Abstract: Embodiments of the present invention are directed to compositions and methods for anti-HIV (anti-CD4 binding site) potent VRC01-like (PVL) antibodies targeted to gp120 having an amino acid substitution at a residue in the anti-CD4 binding site PVL antibody that is equivalent to Phe43 in CD4, these antibodies having improved potency and breadth.
-
公开(公告)号:US11919945B2
公开(公告)日:2024-03-05
申请号:US17519173
申请日:2021-11-04
Applicant: The Rockefeller University
Inventor: Michel Nussenzweig
IPC: C07K16/10 , A61P31/14 , A61K39/42 , G01N33/569 , A61K39/00
CPC classification number: C07K16/10 , A61K39/42 , A61P31/14 , G01N33/56983 , A61K2039/505 , C07K2317/21 , C07K2317/31 , C07K2317/34 , C07K2317/76 , C07K2317/92 , G01N2333/165
Abstract: This disclosure provides novel broadly neutralizing anti-SARS-CoV-2 antibodies or antigen-binding fragments thereof. The disclosed anti-SARS-CoV-2 antibodies constitute a novel therapeutic strategy in protection against SARS-CoV-2 infections.
-
公开(公告)号:US11808702B2
公开(公告)日:2023-11-07
申请号:US17427586
申请日:2020-01-30
Applicant: The Rockefeller University
Inventor: Alipasha Vaziri , Siegfried Weisenburger
CPC classification number: G01N21/6428 , G01N21/6458 , G02B21/16 , G01N2201/06113
Abstract: A multi-photon imaging system includes a laser module having a first channel for outputting a two-photon excitation laser pulse and a second channel for outputting a three-photon excitation laser pulse. The system further includes a first optical path for guiding the two-photon laser pulse from the first channel of the laser module and a second optical path for guiding the three-photon laser pulse from the second channel of the laser module. A microscope is also provided for simultaneously receiving the two-photon laser pulse from the first optical path and the three-photon laser pulse from the second optical path, and simultaneously, or with well controllable delays, delivering the two-photon laser pulse and the three-photon pulse to a target volume. The system further includes a photodetector configured to collect photons generated within the target volume in response to simultaneous excitation of the target volume by both the two-photon laser pulse and the three-photon laser pulse.
-
公开(公告)号:US20230338505A1
公开(公告)日:2023-10-26
申请号:US18319865
申请日:2023-05-18
Applicant: The Rockefeller University
Inventor: Jeffrey V. Ravetch , Taia Wang , Jad Mamaary
IPC: A61K39/145 , A61K39/42 , A61K39/12 , C07K16/10 , A61P31/16 , A61P35/00 , A61K39/00 , A61K45/06 , C07K14/005 , C07K14/47
CPC classification number: A61K39/145 , A61K39/42 , A61K39/12 , C07K16/1018 , A61P31/16 , A61P35/00 , A61K39/0011 , A61K45/06 , C07K14/005 , C07K14/4748 , A61K2039/5252 , A61K2039/55516 , C12N2760/16134 , A61K2039/505 , C07K2317/21 , C07K2317/24 , C07K2317/31 , C07K2317/41 , C07K2317/92 , C07K2317/72 , C07K2317/76
Abstract: The present invention relates to immunogenic immune complexes, related compositions, and related methods.
-
公开(公告)号:US20230331824A1
公开(公告)日:2023-10-19
申请号:US18042448
申请日:2021-08-20
Applicant: The Rockefeller University , New York University , Seattle Children's Hospital d/b/a Seattle Children's Research Institute
Inventor: Brian T. Chait , Michael P. Rout , John Aitchison , Fred David Mast , Jean Paul Olivier , David Fenyo
CPC classification number: C07K16/1003 , A61K47/6829 , A61K47/6827 , A61K47/6825 , A61K47/6821 , A61K47/6819 , A61K47/68031 , A61K47/68033 , A61K47/6809 , A61K47/6805 , A61K51/1006 , C07K14/7051 , A61K39/4631 , A61K39/4611 , A61K39/464838 , A61K39/4633 , A61P31/14 , C07K16/2809 , C07K16/2818 , C07K16/2815 , C07K16/18 , C07K2317/569 , C07K2317/52 , C07K2317/92 , C07K2317/94 , C07K2317/31 , C07K2319/33 , C07K2319/03 , C07K2317/76
Abstract: Single-domain antibodies that bind the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) spike protein are disclosed. The single-domain antibodies include binding domains that bind epitopes of the Spike ectodomain inside and outside the receptor binding domain. The single-domain antibodies can be used for multiple purposes including in the research, diagnosis, and prophylactic or therapeutic treatment of COVID-19.
-
公开(公告)号:US20230287371A1
公开(公告)日:2023-09-14
申请号:US18006251
申请日:2021-07-19
Applicant: The Rockefeller University
Inventor: Luciano MARRAFFINI , Jakob ROSTOL
CPC classification number: C12N9/22 , C12N15/11 , C12N2310/20
Abstract: Provided is an isolated or recombinantly expressed protein comprising the sequence of SEQ ID NO: 1 (CARD1), or an amino acid sequence that is at least 90% identical to the sequence of CARD1. Methods for producing and isolating the CARD1 protein are provided. Also provided are methods that include using CARD1, Cas1O and RNA obtained from a biological sample, and a guide RNA targeted to an RNA polynucleotide that may be in the biological sample, and determining whether or not the CARD1 cleaves a reporter ssDNA or reporter ssRNA that is added to the sample, to determine the presence or absence of the RNA polynucleotide. Kits for use in the assay are also provided.
-
-
-
-
-
-
-
-
-